OUSTZ: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Total revenue	107,206	-
Product manufacturing costs	48,382	-
Stock based compensation and amortization expense	5,939	-
Other costs	6,901	-
Research and development	49,909	-
Sales and marketing	20,842	-
General and administrative	50,136	-
Total other income, net	7,192	-
Provision for (benefit from) income taxes	-3,349	-
Net loss	-64,362	-42,629
Depreciation and amortization	5,707	3,654
Loss on write-off and disposal of property and equipment and right-of-use asset impairment	106	85
Gain on lease termination	65	65
Stock-based compensation	33,553	21,724
Reduction of revenue related to stock warrant issued to customer	2,054	1,021
Amortization of right-of-use asset	3,868	2,509
Accretion or amortization on short-term investments	2,400	1,488
Change in fair value of warrant liabilities	-8	229
(recovery) provision for inventory write-down	-551	465
Provision (recovery) of doubtful accounts	120	137
Realized gain on available for sale securities	4	4
Accounts receivable	2,930	-6,471
Inventory	-455	-2,049
Prepaid expenses and other assets	5,943	3,640
Accounts payable	9,216	6,425
Accrued and other liabilities	6,056	3,978
Contract liabilities	-4,374	-3,836
Operating lease liability	-5,028	-3,273
Net cash used in operating activities	-24,530	-6,188
Proceeds from sale of property and equipment	0	0
Purchases of property and equipment	3,143	1,441
Purchase of short-term investments	118,424	79,686
Proceeds from sales of short-term investments	90,000	57,250
Net cash (used in) provided by investing activities	-31,567	-23,877
Proceeds from espp purchase	980	980
Proceeds from exercise of stock options	83	48
Repayment of borrowings	0	-
Payments received (remitted) to fund employees tax obligation for vested rsus	2,440	357
Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees	94,057	58,798
At-the-market offering costs for the issuance of common stock	232	10
Net cash provided by (used in) financing activities	97,328	60,173
Effect of exchange rates on cash and cash equivalents	436	480
Net increase (decrease) in cash, cash equivalents and restricted cash	41,667	30,588
Cash and cash equivalents at beginning of period	48,099	-
Cash and cash equivalents at end of period	89,766	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

OUSTZ: the cashflow